This information
collection request is approved as amended by FDA. OMB notes that
FDA will forward final versions of the instruments associated with
Phase I of the study and will consult with OMB before administering
Phase II to determine whether and how this information collection
request should be amended to incorporate any changes to the
instruments, methodology and/or the language being tested.
Inventory as of this Action
Requested
Previously Approved
10/31/2010
36 Months From Approved
1,200
0
0
705
0
0
0
0
0
Study of users and potential users of
male latex condoms to evaluate the understandability of the condom
labeling language proposed in a draft guidance as well as future
revised version of the labeling.
US Code:
21
USC 393 Name of Law: Medical Device Admendment
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.